IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today ...

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading provider of hormone optimization, has announced the launch of a new Men’s Health Division with the ...

Biote CEO Terry Weber moved to Dallas from Orange County, Calif., in 2018 to lead the hormone replacement therapy provider into its next stage of growth. The Irving-based company is expecting up to ...

Good afternoon, and welcome to the biote Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the ...

Biote Corp. ((BTMD)) has held its Q3 earnings call. Read on for the main highlights of the call. Biote Corp.’s latest earnings call revealed a mixed sentiment, with challenges and opportunities ...

CEO Bret Christensen noted that "the second quarter was pivotal for Biote as we implemented a strategic organizational restructuring designed to drive increased and sustainable growth." He highlighted ...

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today ...

Represents cash and non-cash interest on our debt obligations, commitment fees for our unused Revolving Loans, net of interest income earned on our money market account. Interest expense, net, ...

Leader in Hormone Education and Training Aims to Increase Awareness and Access to Testosterone Deficiency Therapy through Expanded Network of Urologists and Internal Medicine Practitioners “Men tend ...

biote Corp. beats earnings expectations. Reported EPS is $0.18, expectations were $0.08. biote Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the ...